Trial Profile
Phase II Study of RAD001monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Adenoid cystic carcinoma
- Focus Therapeutic Use
- 19 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Jul 2010 New trial record